secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001213900-25-065723
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuphoria receives Nasdaq deficiency notice for missing annual meeting; plans compliance plan
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 18, 2025 for failure to hold annual meeting within 12 months of fiscal year ended June 30, 2024.
- Must submit compliance plan by September 1, 2025; if accepted, exception until December 29, 2025.
- Company plans to hold 2025 annual meeting in November 2025, consistent with past practice.
- Deficiency notice has no immediate impact on listing of NEUP common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025065723/0001213900-25-065723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025065723/ea0249543-8k_neuphoria.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-065723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer